Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Search
Back to News
January 25, 2017
Endologix Announces Reinstatement of CE Mark for AFX® and AFX®2 Endovascular AAA System
Prev
Previous
Endologix Resumes Shipments of All Sizes of AFX®2 Endovascular AAA Systems Appoints Laura Nagel as Vice President, Global Quality
Next
Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium
Next
